• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 31 of 100
Roche logo
TechRoche to use quantum computing for drug discovery
By Jeremy KahnJanuary 28, 2021
A photo of Jonas Salk injecting a boy with the polio vaccine he invented.
HealthThe COVID-19 vaccination drive may be slow—but it’s already faster than any in history
By Jeremy KahnJanuary 17, 2021
Drug price hikes big pharma 2021
HealthIt’s the New Year, and pharma companies are already hiking prices for popular drugs
By Sy MukherjeeJanuary 4, 2021
Timeline: From the first coronavirus cases to the first vaccinations
HealthTimeline: From the first coronavirus cases to the first vaccinations
By Sy MukherjeeDecember 30, 2020
U.K. Prime Minister Boris Johnson holding a vial of AstraZeneca's Covid-19 vaccine.
HealthU.K. approves AstraZeneca COVID-19 vaccine
By Jeremy KahnDecember 30, 2020
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
HealthSeniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By Harris Meyer and Kaiser Health NewsDecember 28, 2020
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
HealthAstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
COVID vaccine CDC allergies
HealthWhat to know about the CDC’s new COVID vaccine guidance for people with health conditions
By Sy MukherjeeDecember 27, 2020
Doctors and patients face a painkiller crisis, even as they fight COVID
CommentaryDoctors and patients face a painkiller crisis, even as they fight COVID
By Joseph StaufferDecember 16, 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
CommentaryBig Pharma’s new CEOs must step up to erase inequities in drug access
By Jayasree K. IyerDecember 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
FinanceWhy shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
Coronavirus
HealthThe science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
Protein folding image for Eye on A.I.
NewslettersLessons from DeepMind’s breakthrough in protein-folding A.I.
By Jeremy KahnDecember 1, 2020
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
HealthDeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
By Jeremy KahnNovember 30, 2020
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
TechKnow when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
By Jeremy KahnNovember 30, 2020
1...
  • 29
  • 30
  • 31
  • 32
  • 33
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.